AXON
Price
$424.93
Change
+$1.76 (+0.42%)
Updated
Oct 29, 10:53 AM (EDT)
Capitalization
34.38B
7 days until earnings call
Intraday BUY SELL Signals
FBIO
Price
$2.02
Change
+$0.06 (+3.06%)
Updated
Oct 29, 10:59 AM (EDT)
Capitalization
65.37M
15 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AXON vs FBIO

AXON vs FBIO Comparison Chart in %
View a ticker or compare two or three
VS
AXON vs. FBIO commentary
Oct 29, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXON is a Buy and FBIO is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for AXON with price predictions
Oct 28, 2026

AXON's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for AXON turned positive on October 06, 2026. Looking at past instances where AXON's MACD turned positive, the stock continued to rise in 32 of 39 cases over the following month. The odds of a continued upward trend are 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AXON's RSI Oscillator exited the oversold zone, 21 of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.

The Momentum Indicator moved above the 0 level on October 26, 2026. You may want to consider a long position or call options on AXON as a result. In 60 of 76 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.

Following a +1.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where AXON advanced for three days, in 273 of 370 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

AXON may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 50-day moving average for AXON moved below the 200-day moving average on October 23, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXON declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.

The Aroon Indicator for AXON entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 50 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. AXON’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 68 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AXON’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock better than average.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 92 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.356) is normal, around the industry mean (5.023). AXON has a moderately high P/E Ratio (171.324) as compared to the industry average of (16.821). Projected Growth (PEG Ratio) (1.949) is also within normal values, averaging (2.564). Dividend Yield (0.000) settles around the average of (0.060) among similar stocks. P/S Ratio (12.034) is also within normal values, averaging (18.330).

A.I.Advisor
a Summary for FBIO with price predictions
Oct 28, 2026

FBIO in upward trend: price may jump up because it broke its lower Bollinger Band on October 14, 2026

FBIO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 30 of 35 cases where FBIO's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where FBIO's RSI Oscillator exited the oversold zone, 34 of 43 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 56 of 68 cases where FBIO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.

The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on FBIO as a result. In 69 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.

The Moving Average Convergence Divergence (MACD) for FBIO just turned positive on October 20, 2026. Looking at past instances where FBIO's MACD turned positive, the stock continued to rise in 39 of 52 cases over the following month. The odds of a continued upward trend are 75%.

Following a +4.81% 3-day Advance, the price is estimated to grow further. Considering data from situations where FBIO advanced for three days, in 204 of 255 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FBIO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.

The Aroon Indicator for FBIO entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 14 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 57 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.398) is normal, around the industry mean (3.151). P/E Ratio (0.603) is within average values for comparable stocks, (-1.051). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (127.720) among similar stocks. P/S Ratio (1.145) is also within normal values, averaging (439.237).

The Tickeron PE Growth Rating for this company is 65 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 80 (best 1 - 100 worst), indicating slightly worse than average price growth. FBIO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FBIO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

FUNDAMENTALS RATINGS
AXON vs FBIO: Fundamental Ratings
AXON
FBIO
OUTLOOK RATING
1..100
2621
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
57
Fair valued
PROFIT vs RISK RATING
1..100
68100
SMR RATING
1..100
8114
PRICE GROWTH RATING
1..100
6280
P/E GROWTH RATING
1..100
5065
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FBIO's Valuation (57) in the Biotechnology industry is somewhat better than the same rating for AXON (92). This means that FBIO’s stock grew somewhat faster than AXON’s over the last 12 months.

AXON's Profit vs Risk Rating (68) in the Biotechnology industry is in the same range as FBIO (100). This means that AXON’s stock grew similarly to FBIO’s over the last 12 months.

FBIO's SMR Rating (14) in the Biotechnology industry is significantly better than the same rating for AXON (81). This means that FBIO’s stock grew significantly faster than AXON’s over the last 12 months.

AXON's Price Growth Rating (62) in the Biotechnology industry is in the same range as FBIO (80). This means that AXON’s stock grew similarly to FBIO’s over the last 12 months.

AXON's P/E Growth Rating (50) in the Biotechnology industry is in the same range as FBIO (65). This means that AXON’s stock grew similarly to FBIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AXONFBIO
RSI
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 1 day ago
80%
Declines
ODDS (%)
Bearish Trend 11 days ago
70%
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
60%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Oct 29, 2026
Stock price -- (AXON: $423.17 vs. FBIO: $1.96)
Brand notoriety: AXON and FBIO are both not notable
AXON represents the Aerospace & Defense, while FBIO is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AXON: 72% vs. FBIO: 48%
Market capitalization -- AXON: $34.38B vs. FBIO: $65.37M
AXON [@Aerospace & Defense] is valued at $34.38B. FBIO’s [@Biotechnology] market capitalization is $65.37M. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $4.49 to $1.91T. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $134.26B. The average market capitalization across the [@Aerospace & Defense] industry is $38.76B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXON’s FA Score shows that 0 FA rating(s) are green while FBIO’s FA Score has 1 green FA rating(s).

  • AXON’s FA Score: 0 green, 5 red.
  • FBIO’s FA Score: 1 green, 4 red.
According to our system of comparison, FBIO is a better buy in the long-term than AXON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXON’s TA Score shows that 5 TA indicator(s) are bullish while FBIO’s TA Score has 6 bullish TA indicator(s).

  • AXON’s TA Score: 5 bullish, 4 bearish.
  • FBIO’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, FBIO is a better buy in the short-term than AXON.

Price Growth

AXON (@Aerospace & Defense) experienced а +5.11% price change this week, while FBIO (@Biotechnology) price change was +1.03% for the same time period.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was +2.47%. For the same industry, the average monthly price growth was -10.18%, and the average quarterly price growth was -16.08%.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.16%. For the same industry, the average monthly price growth was -7.12%, and the average quarterly price growth was -10.44%.

Reported Earning Dates

AXON is expected to report earnings on Nov 05, 2026.

FBIO is expected to report earnings on Nov 13, 2026.

Industries' Descriptions

@Aerospace & Defense (+2.47% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

@Biotechnology (+8.16% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
AXON
Daily Signal:
Gain/Loss:
FBIO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

AXON and

Correlation & Price change

A.I.dvisor indicates that over the last year, AXON has been loosely correlated with TECH. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if AXON jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXON
1D Price
Change %
AXON100%
-0.63%
TECH - AXON
61%
Loosely correlated
+0.12%
VCYT - AXON
58%
Loosely correlated
+0.06%
BEAM - AXON
57%
Loosely correlated
+15.58%
SEER - AXON
56%
Loosely correlated
+1.53%
ADPT - AXON
56%
Loosely correlated
+2.57%
More

FBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, FBIO has been loosely correlated with AXON. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if FBIO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBIO
1D Price
Change %
FBIO100%
+1.55%
AXON - FBIO
38%
Loosely correlated
-0.63%
CLYM - FBIO
33%
Poorly correlated
+5.75%
QSI - FBIO
32%
Poorly correlated
+4.24%
HYFT - FBIO
31%
Poorly correlated
+1.72%
EDIT - FBIO
31%
Poorly correlated
+13.46%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NVDQ8.990.20
+2.28%
T-Rex 2X Inverse NVIDIA Daily Target ETF (NVDQ)
BLGR32.500.19
+0.59%
Bluemonte Large Cap Growth ETF (BLGR)
YBST11.120.03
+0.28%
GraniteShares YieldBoost Single Stock Universe ETF (YBST)
PJUL50.080.08
+0.16%
Innovator U.S. Equity Power Buffer ETF - July (PJUL)
DDTL22.640.02
+0.07%
Innovator Equity Dual Directional 10 Buffer ETF - July (DDTL)